Mirabella Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Mirabella Financial Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,260	Closed	-$1.32M	–	410
2024 Q2	$1.32M	Buy	1,260 +954	+312%	+$925K	0.1%	117
2024 Q1	$296K	Buy	+306	New	+$291K	0.02%	391
2023 Q3	–	Sell	-521	Closed	-$374K	–	580
2023 Q2	$374K	Buy	+521	New	+$402K	0.04%	336
2022 Q2	–	Sell	-2,627	Closed	-$1.83M	–	677
2022 Q1	$1.83M	Buy	+2,627	New	+$1.66M	0.2%	101
2021 Q4	–	Sell	-4,671	Closed	-$2.83M	–	567
2021 Q3	$2.83M	Buy	+4,671	New	+$2.9M	0.37%	73

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Mirabella Financial Services's REGN Position: Q3 2024 in Review

Mirabella Financial Services sold out of Regeneron Pharmaceuticals (REGN) in Q3 2024, closing a stake of 1,260 shares — an estimated $1.32M sold.

Mirabella Financial Services first reported a position in REGN in Q3 2021 and held it in 5 quarters. The position peaked at $2.83M in Q3 2021. 1,391 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Mirabella Financial Services reported no remaining Regeneron Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Mirabella Financial Services sold 1,260 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $1.32M.
Mirabella Financial Services first reported a position in Regeneron Pharmaceuticals in Q3 2021 and held it in 5 quarters.
Mirabella Financial Services's Regeneron Pharmaceuticals position peaked at $2.83M in Q3 2021.
1,391 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.